XML 30 R19.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS’ EQUITY (Tables)
3 Months Ended
Mar. 31, 2023
Equity [Abstract]  
SCHEDULE OF OPTIONS ACTIVITY

 

  

Shares Under

Options

  

Weighted

Average

Exercise Price

per Share

  

Weighted

Average

Remaining

Life (Years)

 
Outstanding – December 31, 2021   127,000   $31.86    7.77 
Granted   6,000    15.56    9.89 
Exercised   -    -    - 
Outstanding – March 31, 2022   133,000   $26.00    7.63 
                
Outstanding – December 31, 2022   147,619   $24.42    7.24 
Granted   -    -    - 
Exercised   (5,459)   1.40    0.24 
Outstanding – March 31, 2023   142,160   $25.31    7.50 
SCHEDULE OF FAIR VALUE ASSUMPTION FOR OPTIONS GRANTED

The fair value for options granted in the first quarter of 2022 is estimated at the date of grant using a Black-Scholes-Merton options pricing model with the following underlying assumptions:

 

   2022 
Price at valuation  $15.56 
Exercise price  $15.56 
Risk free interest   2.32 
Expected term (in years)   5 
Volatility   127.9 
SCHEDULE OF STOCK BASED EXPENSES RECOGNIZED SERVICES FROM EMPLOYEES AND NON-EMPLOYEES

The total stock-based expense recognized in the financial statements for services received from employees and non-employees is shown in the following table.

 

   2023   2022 
  

Three Months Ended

March 31,

 
   2023   2022 
Research and development   2    2 
Selling and marketing   6    6 
General and administrative   59    78 
Total  $67   $86 
SCHEDULE OF WARRANTS ACTIVITY

For the three months ended March 31, 2023 and 2022, there were no warrants granted, exercised and/ or cancelled.

 

   Warrants 
Outstanding – December 31, 2021   115,467 
Granted   - 
Exercised   - 
Canceled   - 
Outstanding – March 31, 2022   115,467 
      
Outstanding – December 31, 2022   78,252 
Granted   - 
Exercised   - 
Canceled   - 
Outstanding – March 31, 2023   78,252